Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The American Journal of Pathology|May 26, 2006
Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosisGavin Y Oudit, Andrew M Herzenberg, Zamaneh Kassiri, et al.
Arthritis Research & Therapy|October 8, 2016
A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritisCarolina Landolt-Marticorena, Stephenie D Prokopec, Stacey Morrison, et al.
The American Journal of Pathology|June 30, 2007
Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injuryDenise W Wong, Gavin Y Oudit, Heather Reich, et al.
Cytokine|August 2, 2017
Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetesEtienne Sochett, Damien Noone, Michael Grattan, et al.
Rheumatology (Oxford, England)|September 7, 2014
Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosusTimothy Li, Stephenie D Prokopec, Stacey Morrison, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 16, 2014
Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of glomerulonephritis in adultsAndrey V Cybulsky, Michael Walsh, Greg Knoll, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 16, 2014
Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of nephrotic syndrome in childrenSusan Samuel, Martin Bitzan, Michael Zappitelli, et al.
Kidney International|March 29, 2024
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathyRichard Lafayette, Sean Barbour, Rubeen Israni, et al.
Canadian Journal of Kidney Health and Disease|December 9, 2020
Management of Patients With Glomerulonephritis During the COVID-19 Pandemic: Recommendations From the Canadian Society of Nephrology COVID-19 Rapid Response TeamSarah M Moran, Sean Barbour, Christine Dipchand, et al.
Canadian Journal of Kidney Health and Disease|August 15, 2023
Focused Jurisdictional Scan of Glomerulonephritis Medication Access in Canada: A Program ReportRohini Naipaul, Catherine Marques, Jenny Ng, et al.
Pageof 6